# Trial of High-dose Urso in Primary Sclerosing Cholangitis

> **NCT00059202** · PHASE2,PHASE3 · TERMINATED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 150 (actual)

## Conditions studied

- Primary Sclerosing Cholangitis

## Interventions

- **DRUG:** Ursodeoxycholic Acid
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00059202
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-07
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 150 (ACTUAL)
- **Why stopped:** DSMB reviewed interim analysis and terminated the study due to futility.
- **Last updated:** 2021-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00059202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00059202, "Trial of High-dose Urso in Primary Sclerosing Cholangitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00059202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*